MTNB
Price
$0.94
Change
-$0.02 (-2.08%)
Updated
Jun 26 closing price
Capitalization
4.79M
PHIO
Price
$2.21
Change
+$0.04 (+1.84%)
Updated
Jun 26 closing price
Capitalization
10.6M
Interact to see
Advertisement

MTNB vs PHIO

Header iconMTNB vs PHIO Comparison
Open Charts MTNB vs PHIOBanner chart's image
Matinas Biopharma Holdings
Price$0.94
Change-$0.02 (-2.08%)
Volume$121.75K
Capitalization4.79M
Phio Pharmaceuticals
Price$2.21
Change+$0.04 (+1.84%)
Volume$202.88K
Capitalization10.6M
MTNB vs PHIO Comparison Chart in %
Loading...
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTNB vs. PHIO commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTNB is a Buy and PHIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (MTNB: $0.94 vs. PHIO: $2.21)
Brand notoriety: MTNB and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTNB: 37% vs. PHIO: 26%
Market capitalization -- MTNB: $4.79M vs. PHIO: $10.6M
MTNB [@Biotechnology] is valued at $4.79M. PHIO’s [@Biotechnology] market capitalization is $10.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTNB’s FA Score shows that 1 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • MTNB’s FA Score: 1 green, 4 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, MTNB is a better buy in the long-term than PHIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTNB’s TA Score shows that 3 TA indicator(s) are bullish while PHIO’s TA Score has 4 bullish TA indicator(s).

  • MTNB’s TA Score: 3 bullish, 5 bearish.
  • PHIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than MTNB.

Price Growth

MTNB (@Biotechnology) experienced а +4.68% price change this week, while PHIO (@Biotechnology) price change was -6.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

MTNB is expected to report earnings on Apr 15, 2025.

PHIO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHIO($10.6M) has a higher market cap than MTNB($4.79M). MTNB YTD gains are higher at: 84.706 vs. PHIO (22.778). PHIO has higher annual earnings (EBITDA): -7.05M vs. MTNB (-15.35M). PHIO has more cash in the bank: 13.3M vs. MTNB (6.92M). PHIO has less debt than MTNB: PHIO (0) vs MTNB (2.71M). MTNB (0) and PHIO (0) have equivalent revenues.
MTNBPHIOMTNB / PHIO
Capitalization4.79M10.6M45%
EBITDA-15.35M-7.05M218%
Gain YTD84.70622.778372%
P/E RatioN/A0.01-
Revenue00-
Total Cash6.92M13.3M52%
Total Debt2.71M0-
FUNDAMENTALS RATINGS
MTNB vs PHIO: Fundamental Ratings
MTNB
PHIO
OUTLOOK RATING
1..100
7884
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3840
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
26n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTNB's Valuation (26) in the Biotechnology industry is in the same range as PHIO (58). This means that MTNB’s stock grew similarly to PHIO’s over the last 12 months.

MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PHIO (100). This means that MTNB’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's SMR Rating (98) in the Biotechnology industry is in the same range as MTNB (99). This means that PHIO’s stock grew similarly to MTNB’s over the last 12 months.

MTNB's Price Growth Rating (38) in the Biotechnology industry is in the same range as PHIO (40). This means that MTNB’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's P/E Growth Rating (66) in the Biotechnology industry is somewhat better than the same rating for MTNB (100). This means that PHIO’s stock grew somewhat faster than MTNB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTNBPHIO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 22 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
MTNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPUS1.430.10
+7.52%
Hyperscale Data Inc
CLNE1.890.06
+3.28%
Clean Energy Fuels Corp
FTK14.660.32
+2.23%
Flotek Industries
IBKR53.411.15
+2.20%
Interactive Brokers Group Inc
TGLS76.111.40
+1.87%
Tecnoglass

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
+1.84%
MTNB - PHIO
50%
Loosely correlated
-2.29%
TPST - PHIO
49%
Loosely correlated
-0.84%
SAGE - PHIO
40%
Loosely correlated
+0.32%
IMNN - PHIO
39%
Loosely correlated
-4.44%
BPMC - PHIO
35%
Loosely correlated
-0.08%
More